|
|||||
|
|
Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer |
|
| Authors: | Richard Kelly Angelyn Anton Shirley Wong Julia Shapiro Andrew Weickhardt Arun Azad Edmond Michael Kwan Lavinia Spain Arun Muthusamy Javier Torres Phillip Parente Francis Parnis Jeffrey Goh Anthony Joshua David Pook Olivia Baenziger Peter Gibbs Ben Tran |
| Affiliation: | 1. Walter and Eliza Hall Institute, Melbourne, Vic., Australia;2. Western Health, Melbourne, Vic., Australia;3. Alfred Health, Melbourne, Vic., Australia;4. Olivia Newton-John Cancer Wellness and Research Centre, Melbourne, Vic., Australia;5. Monash University, Melbourne, Vic., Australia;6. Monash University, Melbourne, Vic., Australia Monash Health, Melbourne, Vic., Australia;7. Eastern Health, Melbourne, Vic., Australia Monash University, Melbourne, Vic., Australia;8. Goulburn Valley Health, Shepparton, Vic., Australia;9. Adelaide Cancer Centre, Adelaide, SA, Australia University of Adelaide, Adelaide, SA, Australia;10. Royal Brisbane and Women’s Hospital, Brisbane, Qld, Australia;11. St Vincent’s Hospital, Sydney, NSW, Australia;12. Monash University, Melbourne, Vic., Australia Peter MacCallum Cancer Centre, Melbourne, Vic., Australia;13. Walter and Eliza Hall Institute, Melbourne, Vic., Australia Western Health, Melbourne, Vic., Australia |
| Abstract: | |
| Keywords: | prostate cancer first-generation antiandrogen real-world data #ProstateCancer #PCSM #uroonc |